Rigel Pharmaceuticals
RIGL
RIGL
106 hedge funds and large institutions have $115M invested in Rigel Pharmaceuticals in 2023 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 34 increasing their positions, 34 reducing their positions, and 17 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
less funds holding
Funds holding: →
20% less capital invested
Capital invested by funds: $143M → $115M (-$28M)
65% less first-time investments, than exits
New positions opened: 6 | Existing positions closed: 17
Holders
106
Holding in Top 10
–
Calls
$887K
Puts
$90K
Top Buyers
| 1 | +$3.37M | |
| 2 | +$1.25M | |
| 3 | +$675K | |
| 4 |
GCP
GSA Capital Partners
London,
United Kingdom
|
+$662K |
| 5 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
+$237K |
Top Sellers
| 1 | -$2.23M | |
| 2 | -$1.61M | |
| 3 | -$1.61M | |
| 4 |
Millennium Management
New York
|
-$1.49M |
| 5 |
Two Sigma Advisers
New York
|
-$1.26M |